Azra Raza
Section of Myeloid Diseases and MDS Center
Rush University
Rush-Presbyterian-St. Luke's Medical Center
2242 West Harrison Street
USA
Name/email consistency: high
- Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Raza, A., Buonamici, S., Lisak, L., Tahir, S., Li, D., Imran, M., Chaudary, N.I., Pervaiz, H., Gallegos, J.A., Alvi, M.I., Mumtaz, M., Gezer, S., Venugopal, P., Reddy, P., Galili, N., Candoni, A., Singer, J., Nucifora, G. Leuk. Res. (2004)
- Remicade as TNF suppressor in patients with myelodysplastic syndromes. Raza, A., Candoni, A., Khan, U., Lisak, L., Tahir, S., Silvestri, F., Billmeier, J., Alvi, M.I., Mumtaz, M., Gezer, S., Venugopal, P., Reddy, P., Galili, N. Leuk. Lymphoma (2004)